Bo Biering-Sørensen

Senior Consultant, Associate Professor and Director of Movement Disorder Clinic, Spasticity Clinic, Neurological pain clinic

Rigshospitalet

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Bo Biering-Sørensen is a Senior Consultant, Associate Professor, and Director of the Movement Disorder Clinic, Spasticity Clinic, and Neurological Pain Clinic at Rigshospitalet in Denmark. His research primarily focuses on the diagnosis and multimodal management of movement disorders, including the use of botulinum toxin therapy for various conditions. Recent publications emphasize topics such as spastic paresis, complex regional pain syndrome, and methodologies for improving patient care in spasticity management.

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Monica Verduzco-Gutierrez

Professor and Chair

UNITED STATES

View details

Rigmor Højland Jensen

Professor, Director

Rigshospitalet

DENMARK

View details

Kristian Kjær-Staal Petersen

Aalborg University

DENMARK

View details

Francois Genet

Université Paris-Saclay

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bo Biering-Sørensen

Research Interests

Contact this professor

About

Articles (11)

Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions

Intramuscular Botulinum Toxin for Complex Regional Pain Syndrome: A Narrative Review of Published Cases

Delphi Analysis: Optimizing Anatomy Teaching and Ultrasound Training for Botulinum Neurotoxin Type A Injection in Spasticity and Dystonia

Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: protocol for a phase II, single-centre, double-blind, randomised, placebo-controlled trial (the PINBOT study).

Spastic Paresis: A Treatable Movement Disorder

Methodology considerations for ‘Safety and effectiveness of cannabinoids to Danish patients with treatment‐refractory chronic pain’ by Horsted et al.

EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A

Dose per muscle in cervical dystonia: pooled data from seven movement disorder centres

Frequency of different subtypes of cervical dystonia: a prospective multicenter study according to Col-Cap concept

Preferred muscles in cervical dystonia

Tremor in Idiopathic Cervical Dystonia - Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap Classification

Collaborators (4)

Monica Verduzco-Gutierrez

Rigmor Højland Jensen

Kristian Kjær-Staal Petersen

Francois Genet

Make your next move.